EBV & HHV8 and HIV in B cell non Hodgkin lymphoma in Kampala, Uganda
dc.contributor.author | Tumwine, Lynnette K. | |
dc.contributor.author | Orem, Jackson | |
dc.contributor.author | Kerchan, Patrick | |
dc.contributor.author | Byarugaba, Wilson | |
dc.contributor.author | Pileri, Stefano A. | |
dc.date.accessioned | 2021-12-12T18:10:20Z | |
dc.date.available | 2021-12-12T18:10:20Z | |
dc.date.issued | 2010 | |
dc.description.abstract | B cell non Hodgkin lymphomas account for the majority of lymphomas in Uganda. The commonest is endemic Burkitt lymphoma, followed by diffuse large-B-cell lymphoma (DLBCL). There has been an increase in incidence of malignant lymphoma since the onset of the HIV/AIDS pandemic. However, the possible linkages of HHV8 and EBV to the condition of impaired immunity present in AIDS are still not yet very clearly understood. | en_US |
dc.identifier.citation | Tumwine et al., EBV, HHV8 and HIV in B cell non Hodgkin lymphoma in Kampala, Uganda Infectious Agents and Cancer 2010, 5:12. doi: 10.1186/1750-9378-5-12 | en_US |
dc.identifier.other | 10.1186/1750-9378-5-12 | |
dc.identifier.uri | https://nru.uncst.go.ug/xmlui/handle/123456789/374 | |
dc.language.iso | en | en_US |
dc.publisher | Uganda Infectious Agents and Cancer | en_US |
dc.subject | EBV | en_US |
dc.subject | HHV8 | en_US |
dc.subject | HIV | en_US |
dc.subject | B cell non Hodgkin lymphoma | en_US |
dc.subject | Uganda | en_US |
dc.title | EBV & HHV8 and HIV in B cell non Hodgkin lymphoma in Kampala, Uganda | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- EBV, HHV8 and HIV in B cell non Hodgkin lymphoma in Kampala, Uganda.pdf
- Size:
- 638.26 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: